The £3 million Tumour Profiling Unit (TPU) in London is to research the use of DNA mapping to identify patients' cancer strains. It is hoped the technique will pave the way for radical new forms of diagnosis, surveillance and targeted therapy.
One aim of the research is to develop "liquid biopsies" that search for free-floating cancer DNA in samples of blood. This can then be used to identify and monitor cancer sub-types that are likely to respond to particular drugs.
Another, controversial, proposal is the use of "mouse avatars" that mirror a patient's disease progression.
Tumour samples from patients will be implanted into mice which will then be observed closely to spot early signs of molecular change and resistance to therapy.
More top news
Virgin's services will only be classed as on time if they reach their destination within less than a minute of the scheduled arrival time.
Banks and building societies should improve efforts to support age-friendly banking, according to a report from Age UK.
The pop star has teamed up with DJ Zedd on the single 'True Colors' which is her first new music for three years.